Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 25.82 USD 8.53% Market Closed
Market Cap: 136.3m USD
Have any thoughts about
Monopar Therapeutics Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

-21.9
Current
-3.6
Median
3.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-21.9
=
Enterprise Value
130.3m USD
/
FCFF
-6m USD
All Countries
Close
Market Cap EV/FCFF
US
Monopar Therapeutics Inc
NASDAQ:MNPR
136.3m USD -21.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 369.5
US
Abbvie Inc
NYSE:ABBV
310.3B USD 23.1
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 30.1
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD -70.1
US
Epizyme Inc
F:EPE
94.1B EUR -470.6
AU
CSL Ltd
ASX:CSL
133.7B AUD 61.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 21.1
US
Seagen Inc
F:SGT
39.3B EUR -56.8
NL
argenx SE
XBRU:ARGX
36.2B EUR -106.5
 
US
Monopar Therapeutics Inc
NASDAQ:MNPR
Average EV/FCFF: 29.5
Negative Multiple: -21.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 369.5
US
Abbvie Inc
NYSE:ABBV
23.1
US
Amgen Inc
NASDAQ:AMGN
30.1
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -70.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.6
AU
CSL Ltd
ASX:CSL
61.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -106.5

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More